Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Deichmann

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Melanoma Research|July 27, 2001
Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100beta or melanoma inhibitory activity (MIA)?M Deichmann, A Benner, N Kuner, et al.
British Journal of Cancer|July 2, 1999
The human herpesvirus-type 8 is not involved in malignant melanomaM Deichmann, M Thome, M Bock, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 25, 2000
Prognosis of metastatic melanoma: no correlation of tyrosinase mRNA in bone marrow and survival timeV Waldmann, J Wacker, M Deichmann, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2001
Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanomaM Deichmann, A Benner, V Waldmann, et al.
British Journal of Cancer|November 28, 2002
PTEN/MMAC1 expression in melanoma resection specimensM Deichmann, M Thome, A Benner, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 31, 1999
[Pathogenesis of malignant melanoma. Molecular biology aspect]V Waldmann, M Bock, A Jäckel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanomaM Deichmann, A Benner, M Bock, et al.
Oncology|September 20, 2002
Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimensM Deichmann, J Mollenhauer, B Helmke, et al.
The British Journal of Dermatology|February 17, 1999
Non-human immunodeficiency virus Kaposi's sarcoma can be effectively treated with low-dose interferon-alpha despite the persistence of herpesvirus-8M Deichmann, M Thome, A Jäckel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Massive lethal cerebral bleeding in a patient with melanoma without intracranial metastasisM Deichmann, B Helmke, M Bock, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Melanoma Research|July 27, 2001
Are responses to therapy of metastasized malignant melanoma reflected by decreasing serum values of S100beta or melanoma inhibitory activity (MIA)?M Deichmann, A Benner, N Kuner, et al.
British Journal of Cancer|July 2, 1999
The human herpesvirus-type 8 is not involved in malignant melanomaM Deichmann, M Thome, M Bock, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|November 25, 2000
Prognosis of metastatic melanoma: no correlation of tyrosinase mRNA in bone marrow and survival timeV Waldmann, J Wacker, M Deichmann, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2001
Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanomaM Deichmann, A Benner, V Waldmann, et al.
British Journal of Cancer|November 28, 2002
PTEN/MMAC1 expression in melanoma resection specimensM Deichmann, M Thome, A Benner, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|July 31, 1999
[Pathogenesis of malignant melanoma. Molecular biology aspect]V Waldmann, M Bock, A Jäckel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanomaM Deichmann, A Benner, M Bock, et al.
Oncology|September 20, 2002
Analysis of losses of heterozygosity of the candidate tumour suppressor gene DMBT1 in melanoma resection specimensM Deichmann, J Mollenhauer, B Helmke, et al.
The British Journal of Dermatology|February 17, 1999
Non-human immunodeficiency virus Kaposi's sarcoma can be effectively treated with low-dose interferon-alpha despite the persistence of herpesvirus-8M Deichmann, M Thome, A Jäckel, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|October 9, 1998
Massive lethal cerebral bleeding in a patient with melanoma without intracranial metastasisM Deichmann, B Helmke, M Bock, et al.
Pageof 4